Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting

Ferrofluids coated with starch polymers can be used as biocompatible carriers. Bound to medical drugs, such magnetic particles can be enriched in a desired body compartment using an external magnetic field. In the present study, we confirm the enrichment of ferrofluids in tumor tissue using histological investigations and conventional imaging techniques, i.e. X-ray and MRI.

[1]  W. Hiddemann,et al.  Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM). , 1990, Leukemia.

[2]  T Grogan,et al.  An Update on “Special Stain” Histochemistry with Emphasis on Automation , 2000, Advances in anatomic pathology.

[3]  M. Engelhard,et al.  Sequential studies on the role of mitoxantrone, high-dose cytarabine, and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of refractory non-Hodgkin's lymphoma. , 1990, Seminars in oncology.

[4]  J. Bading,et al.  Intraarterial versus intravenous adriamycin in the rabbit Vx‐2 tumor system , 1984, Cancer.

[5]  J. Alksne,et al.  Magnetically controlled metallic thrombosis of intracranial aneurysms , 1966 .

[6]  S K Hilal,et al.  Magnetically guided devices for vascular exploration and treatment. , 1974, Radiology.

[7]  Christian Bergemann,et al.  Physiological aspects in magnetic drug-targeting , 1999 .

[8]  P Reichardt,et al.  Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors. , 1996, Cancer research.

[9]  C. Bergemann,et al.  Magnetic ion-exchange nano- and microparticles for medical, biochemical and molecular biological applications , 1999 .

[10]  C T Hung,et al.  Targeted delivery of low dose doxorubicin hydrochloride administered via magnetic albumin microspheres in rats. , 1990, Journal of microencapsulation.

[11]  Urs O. Häfeli,et al.  Scientific and clinical applications of magnetic carriers , 1997 .

[12]  T. Wada,et al.  A ferrofluidic actuator for an implantable artificial heart. , 1992, Artificial organs.

[13]  J. Daly,et al.  Microspheres and Regional Cancer Therapy , 1993 .